We determined the effect of 17β-estradiol (E2) on synthesis and release of luteinizing hormone (LH) induced by drugs which activate intracellular signal transduction mechanisms in rat anterior pituitary cells. Cells were pretreated with E2 (6 × 10–10M) or diluent for 24 h, then washed and incubated for 4 h with E2 or diluent, respectively, in the presence or absence of drugs. LH translation and glycosylation were monitored by measuring incorporation of [14C]alanine and [3H]glucosamine, respectively, into total (medium plus cells) immunoprecipitable LH. Immunoreactive LH (IRLH) was measured by radioimmunoassay. Gonadotropin-releasing hormone (GnRH, 1 ILM), veratridine (5 µM), L-α-1,2-dioctanoyl glycerol (C8, 200 µM), and phospholipase C (PLC, 0.24 U/ml) all increased (p < 0.01) medium IRLH, [3H]glucosamine-LH, and [14C]alanine-LH, and total [3H]glucosamine-LH in both E2- and diluent-treated cells. Total IRLH or [14C]alanine-LH were not increased by any treatment. E2 alone slightly increased (p < 0.05) basal medium IRLH and [3H]glucosamine-LH. The stimulatory effects of E2 on basal medium [14C]alanine-LH and total [3H]glucosamine-LH were inconsistent. E2 potentiated (p < 0.01) the effects of veratridine, C8, PLC, and GnRH on medium IRLH, and medium and total [3H]glucosamine-LH. E2 also potentiated (p < 0.01) the effects of veratridine, PLC, and GnRH, but not of C8, on medium [14C]alanine-LH. In contrast, E2 did not increase either precursor uptake or incorporation of precursor into total protein in the presence of any secretagogue. These results suggest that LH glycosylation, like LH release, may involve the Ca2+ and PLC pathways, and that E2 augments LH glycosylation and release by interacting with these pathways.